Importantly, CHMP4C is closely correlated with prostate cancer clinicopathological parameters and prognosis, indicating that CHMP4C can be used as a novel diagnostic and prognostic molecular marker for prostate cancer. This evidence concerns the gene CHMP4C and Familial prostate cancer.